IP Library › Granted Patent US 8,157,812
Granted Patent B2
US 8,157,812 · App. 12/208,188 · Granted Apr 17, 2012

Slotted deployment device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,157,812
App. No.
12/208,188
Granted
Apr 17, 2012
Kind
B2
Abstract

A delivery cannula for a site marker deployment device is disclosed. The delivery cannula includes a cannula having a tubular sidewall and at least one slot intersecting through the side wall. Each slot is sized to have a predetermined width so as to be configured to receive at least one filament of a site marker. When the site marker is inserted into the delivery cannula, at least a portion of the filament extends outwardly from the cannula and through the slot. A deployment system is also disclosed.

Claims (12)

1. A site marker deployment system comprising:

a deployment device having a delivery cannula and at least one slot; and

a site marker including at least one generally elongated filament member selectively configurable between a first deployed configuration, wherein the site marker can not be interposed within the delivery cannula, and a second configuration, wherein the site marker is selectively interposed within the delivery cannula;

wherein the delivery cannula is configured to selectively retain the site marker, such that at least a portion of the site marker is interposed within the delivery cannula and at least a portion of the at least one filament of the site marker extends into at least one slot in the delivery cannula, wherein the slot extends through the thickness of a sidewall of the delivery cannula.

2. The system of claim 1 , further comprising a push rod at least partially interposed within the delivery cannula, wherein the site marker, when interposed within the delivery cannula, is selectively axially moved by movement of the push rod.

3. The system of claim 2 , wherein the site marker further includes a plurality of filament members and the delivery cannula further includes a plurality of slots.

4. The system of claim 3 , wherein the slots are spaced equidistant about a circumference of the delivery cannula.

5. The system of claim 4 , wherein the slots are oriented so as to be generally parallel to a central axis extending through the delivery cannula.

6. The system of claim 3 , wherein the site marker is defined, at least in part, by an end connection that connects the plurality of filament members together.

7. The system of claim 3 , wherein of the filament members further includes a separate marker element secured thereto.

8. The system of claim 1 , wherein (i) when the site marker is not interposed within the delivery cannula, at least a portion of the site marker expands to a deployed configuration where a dimension of the site marker measured generally normal to a generally central axis of the delivery cannula is greater than a diameter of the delivery cannula; and (ii) when the site marker is interposed within the delivery cannula, at least a portion of the site marker is deformed into a retracted configuration whereby a dimension of the site marker measured generally normal to the generally central axis of the delivery cannula is less than the diameter of the delivery cannula.

9. The system of claim 1 , wherein the at least one filament extends through the slot and outwardly from the delivery cannula.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS Recorded Aug 26, 2010
From: GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT
To: HOLOGIC, INC.; R2 TECHNOLOGY, INC.; SUROS SURGICAL SYSTEMS, INC.; BIOLUCENT, LLC; DIRECT RADIOGRAPHY CORP.; CYTYC SURGICAL PRODUCTS II LIMITED PARTNERSHIP; CYTYC SURGICAL PRODUCTS LIMITED PARTNERSHIP; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS III, INC.; CYTYC PRENATAL PRODUCTS CORP.; THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 024892/0001 →
THIRD SUPPLEMENT TO PATENT SECURITY AGREEMENT Recorded Nov 10, 2008
From: SUROS SURGICAL SYSTEMS, INC.
To: GOLDMAN SACHS CREDIT PARTNERS L.P., AS COLLATERAL AGENT
Reel/Frame 021812/0424 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2008
From: BARR, AARON P.
To: SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 021510/0029 →